Your basic understanding of IBX's technology is way off the mark (don't get me started on the antibody theory).
IBX's test is NOT designed as a screening test. We aren't designing some pan-cancer nanomolecule. Not every female will get a MRI using IBX's nanoparticles instead of a mammogram, nor a female who detects a breast lump. They will go down the same diagnosis pathway as before - usually ultrasound then biopsy. If they then received a diagnosis of HER2 positive breast cancer then they may get a MRI + nanoparticle scan to look for lymph node spread. The nanoparticle is highly specific for that type of cancer only, and wouldn't create a signal at other types of cancer.
- Forums
- ASX - By Stock
- Ann: Imagion to complete the MagSense HER2 Phase 1 Study
Your basic understanding of IBX's technology is way off the mark...
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IBX (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.415M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
IBX (ASX) Chart |
Day chart unavailable